Slide 1Public Cloud Stack Deep Dive Enterprise Cloud Summit Slide 2 Main elements of your service What are your main service offerings (i.e. the top 3 technologies, services,…

Slide 1AGIR 2 Presenter Disclosure Information Eric Bonnefoy The following relationships exist related to this presentation: Research grantsMerck & Co, Iroko LabImportant…

Slide 1Patient Oriented Therapy for STE-MI Seçkin Pehlivanoğlu, MD Başkent University, İstanbul Hospital Slide 2 Patient Oriented Therapy for STE-MI Q: What are the spesific…

Slide 1A Next Generation OCS Welcome to Horner Operator Control Station Training Slide 2 A Next Generation OCS Class Agenda - Building Automation Discussion - Product Overview/Capabilities…

Slide 1Inpatient Medicine: Year in Review Karen Hauer, MD UCSF August, 2006 Slide 2 Methods Literature review March 2005 - 2006 11 major journals Am J MedCirculation Annals…

Slide 1Should we use bivalirudin ? Fibrin 2 1 Thrombin 2 1 Thrombin 2 1 Trombina 2 1 Trombina Bivalirudin ADVANTAGES - No requirement for anti-thrombin III - Effective on…

Slide 1CURRENT OASIS 7: A 2X2 Factorial Randomized Trial of Optimal Clopidogrel and Aspirin Dosing in Patients with ACS Undergoing an Early Invasive Strategy with Intent…

Slide 12013 ACCF/AHA/SCAI Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures A Report of the American College of Cardiology Foundation/American…

Slide 1Unstable angina and NSTEMI Implementing NICE guidance March 2010 NICE clinical guideline 94 Slide 2 Updated guidance This guideline updates and replaces recommendations…

Slide 1Österr.Kardiol.Gesellschaft 1990 Arbeitsgruppe Intervent. Kardiologie n H. Mlczoch n W.Klein(+) n P.Probst n F.Leisch n V.Mühlberger Monitor (Auditor) Report: 2005…